Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Articles
ALL – Clinical Oral Presentations: Saturday, June 11
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
ALL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Blinatumomab Demonstrates Overall Survival Benefit in Adults with Relapsed ALL in the TOWER Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
CD19 CAR T Cells Induce Potent Responses and Control CNS Leukemia in Relapsed ALL
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
CLL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Duration of TKI Treatment and Duration of Deep Molecular Response Affect Relapse-Free Survival in CML
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Higher-Dose Daunorubicin Is Effective in Patients with AML Who Harbor FLT3-ITD Mutations
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Ibrutinib plus Bendamustine and Rituximab (BR) in Previously Treated CLL/SLL: 2-Year Follow-Up Data from the HELIOS Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Innovative Therapies in CLL: Saturday, June 11
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Length of Time on Treatment Observed in Ibrutinib Clinical Trials Is Reproducible After Assessment of Real-World Data
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read More
Page 161 of 329
158
159
160
161
162
163
164
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma